Frequencies for first 10,000 rows of indi_pt variable in indi2009q3 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 6 0.06 0.06 ABDOMINAL INFECTION | 1 0.01 0.07 ABDOMINAL MASS | 1 0.01 0.08 ABDOMINAL PAIN | 15 0.15 0.23 ABDOMINAL PAIN UPPER | 3 0.03 0.26 ABNORMAL BEHAVIOUR | 4 0.04 0.30 ABNORMAL FAECES | 2 0.02 0.32 ABSCESS | 3 0.03 0.35 ACCIDENTAL EXPOSURE | 3 0.03 0.38 ACCIDENTAL OVERDOSE | 3 0.03 0.41 ACNE | 30 0.30 0.71 ACQUIRED HAEMOPHILIA | 1 0.01 0.72 ACROMEGALY | 2 0.02 0.74 ACTINIC KERATOSIS | 1 0.01 0.75 ACUTE CORONARY SYNDROME | 11 0.11 0.86 ACUTE LYMPHOCYTIC LEUKAEMIA | 19 0.19 1.05 ACUTE MYELOID LEUKAEMIA | 21 0.21 1.26 ACUTE MYELOID LEUKAEMIA RECURRENT | 4 0.04 1.30 ACUTE MYOCARDIAL INFARCTION | 13 0.13 1.43 ACUTE RESPIRATORY DISTRESS SYNDROME | 1 0.01 1.44 ACUTE SINUSITIS | 1 0.01 1.45 ACUTE TONSILLITIS | 2 0.02 1.47 ADENOCARCINOMA | 1 0.01 1.48 ADENOIDECTOMY | 24 0.24 1.72 ADJUVANT THERAPY | 1 0.01 1.73 ADRENAL INSUFFICIENCY | 3 0.03 1.76 ADVERSE DRUG REACTION | 2 0.02 1.78 AFFECTIVE DISORDER | 6 0.06 1.84 AGGRESSION | 1 0.01 1.85 AGITATION | 6 0.06 1.91 AGORAPHOBIA | 1 0.01 1.92 ALCOHOLIC | 1 0.01 1.93 ALCOHOLISM | 1 0.01 1.94 ALLERGENIC DESENSITISATION PROCEDURE | 1 0.01 1.95 ALLERGIC BRONCHITIS | 1 0.01 1.96 ALLERGY PROPHYLAXIS | 2 0.02 1.98 ALLERGY TO ANIMAL | 1 0.01 1.99 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 4 0.04 2.03 ALOPECIA | 14 0.14 2.17 AMNESIA | 1 0.01 2.18 AMYLOIDOSIS | 4 0.04 2.22 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.23 ANAEMIA | 14 0.14 2.37 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 2.38 ANAEMIA OF CHRONIC DISEASE | 1 0.01 2.39 ANAEMIA OF MALIGNANT DISEASE | 3 0.03 2.42 ANAESTHESIA | 28 0.28 2.70 ANALGESIA | 7 0.07 2.77 ANALGESIC THERAPY | 11 0.11 2.88 ANGINA PECTORIS | 14 0.14 3.02 ANGIOEDEMA | 2 0.02 3.04 ANGIOGRAM | 1 0.01 3.05 ANGIOPATHY | 1 0.01 3.06 ANGIOSARCOMA | 3 0.03 3.09 ANIMAL BITE | 1 0.01 3.10 ANKYLOSING SPONDYLITIS | 17 0.17 3.27 ANTI-GLOMERULAR BASEMENT MEMBRANE ANT.. | 4 0.04 3.31 ANTIALLERGIC THERAPY | 1 0.01 3.32 ANTIBIOTIC PROPHYLAXIS | 10 0.10 3.42 ANTIBIOTIC THERAPY | 2 0.02 3.44 ANTICOAGULANT THERAPY | 9 0.09 3.53 ANTIDEPRESSANT THERAPY | 9 0.09 3.62 ANTIEMETIC SUPPORTIVE CARE | 7 0.07 3.69 ANTIFUNGAL PROPHYLAXIS | 3 0.03 3.72 ANTIFUNGAL TREATMENT | 1 0.01 3.73 ANTIINFLAMMATORY THERAPY | 6 0.06 3.79 ANTIPLATELET THERAPY | 4 0.04 3.83 ANTIRETROVIRAL THERAPY | 5 0.05 3.88 ANTITUSSIVE THERAPY | 1 0.01 3.89 ANTIVIRAL PROPHYLAXIS | 4 0.04 3.93 ANTIVIRAL TREATMENT | 9 0.09 4.02 ANXIETY | 81 0.81 4.83 ANXIETY DISORDER | 2 0.02 4.85 AORTIC VALVE DISEASE | 1 0.01 4.86 APLASIA PURE RED CELL | 1 0.01 4.87 APLASTIC ANAEMIA | 6 0.06 4.93 APPLICATION SITE INFECTION | 1 0.01 4.94 ARRHYTHMIA | 18 0.18 5.12 ARTERIOSCLEROSIS | 5 0.05 5.17 ARTERIOSCLEROSIS CORONARY ARTERY | 1 0.01 5.18 ARTERIOSCLEROSIS OBLITERANS | 1 0.01 5.19 ARTHRALGIA | 29 0.29 5.48 ARTHRITIS | 24 0.24 5.72 ARTHRITIS BACTERIAL | 4 0.04 5.76 ARTHROPATHY | 1 0.01 5.77 ARTHROPOD BITE | 1 0.01 5.78 ASCITES | 1 0.01 5.79 ASPERGER'S DISORDER | 1 0.01 5.80 ASPERGILLOSIS | 10 0.10 5.90 ASTHENIA | 1 0.01 5.91 ASTHMA | 122 1.22 7.13 ATRIAL FIBRILLATION | 35 0.35 7.48 ATRIAL FLUTTER | 2 0.02 7.50 ATRIAL THROMBOSIS | 2 0.02 7.52 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 18 0.18 7.70 ATYPICAL MYCOBACTERIAL INFECTION | 2 0.02 7.72 AUTISM | 2 0.02 7.74 AUTOIMMUNE THYROIDITIS | 1 0.01 7.75 AUTOLOGOUS BONE MARROW TRANSPLANTATIO.. | 3 0.03 7.78 B PRECURSOR TYPE ACUTE LEUKAEMIA | 3 0.03 7.81 B-CELL LYMPHOMA | 24 0.24 8.05 B-CELL LYMPHOMA STAGE III | 4 0.04 8.09 BACK DISORDER | 1 0.01 8.10 BACK PAIN | 51 0.51 8.61 BACTERAEMIA | 15 0.15 8.76 BACTERIAL DISEASE CARRIER | 1 0.01 8.77 BACTERIAL INFECTION | 4 0.04 8.81 BEHCET'S SYNDROME | 5 0.05 8.86 BENIGN PROSTATIC HYPERPLASIA | 20 0.20 9.06 BICYTOPENIA | 1 0.01 9.07 BIOPSY | 1 0.01 9.08 BIPOLAR DISORDER | 34 0.34 9.42 BIPOLAR I DISORDER | 5 0.05 9.47 BIPOLAR II DISORDER | 1 0.01 9.48 BLADDER CANCER | 6 0.06 9.54 BLADDER DISCOMFORT | 1 0.01 9.55 BLADDER DISORDER | 2 0.02 9.57 BLADDER PAIN | 1 0.01 9.58 BLADDER TRANSITIONAL CELL CARCINOMA | 2 0.02 9.60 BLOOD CALCIUM DECREASED | 1 0.01 9.61 BLOOD CHOLESTEROL | 23 0.23 9.84 BLOOD CHOLESTEROL ABNORMAL | 3 0.03 9.87 BLOOD CHOLESTEROL INCREASED | 33 0.33 10.20 BLOOD COUNT ABNORMAL | 1 0.01 10.21 BLOOD DISORDER | 2 0.02 10.23 BLOOD GLUCOSE | 1 0.01 10.24 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 10.25 BLOOD PHOSPHORUS INCREASED | 1 0.01 10.26 BLOOD POTASSIUM DECREASED | 2 0.02 10.28 BLOOD PRESSURE | 33 0.33 10.61 BLOOD PRESSURE ABNORMAL | 1 0.01 10.62 BLOOD PRESSURE INCREASED | 9 0.09 10.71 BLOOD PRESSURE MANAGEMENT | 2 0.02 10.73 BLOOD TRIGLYCERIDES | 1 0.01 10.74 BLOOD TRIGLYCERIDES INCREASED | 5 0.05 10.79 BLOOD URIC ACID | 1 0.01 10.80 BLOOD URIC ACID INCREASED | 1 0.01 10.81 BODY TEMPERATURE INCREASED | 2 0.02 10.83 BONE DISORDER | 3 0.03 10.86 BONE LESION | 3 0.03 10.89 BONE MARROW CONDITIONING REGIMEN | 2 0.02 10.91 BONE MARROW FAILURE | 1 0.01 10.92 BONE MARROW TRANSPLANT | 1 0.01 10.93 BONE NEOPLASM MALIGNANT | 1 0.01 10.94 BONE PAIN | 5 0.05 10.99 BOWEL MOVEMENT IRREGULARITY | 1 0.01 11.00 BRAIN ABSCESS | 17 0.17 11.17 BRAIN INJURY | 1 0.01 11.18 BRAIN NEOPLASM MALIGNANT | 1 0.01 11.19 BRAIN OEDEMA | 1 0.01 11.20 BRAIN STEM HAEMORRHAGE | 4 0.04 11.24 BREAKTHROUGH PAIN | 6 0.06 11.30 BREAST CANCER | 100 1.00 12.30 BREAST CANCER METASTATIC | 36 0.36 12.66 BREAST CANCER RECURRENT | 2 0.02 12.68 BRONCHIAL CARCINOMA | 1 0.01 12.69 BRONCHITIS | 12 0.12 12.81 BRONCHITIS BACTERIAL | 1 0.01 12.82 BRONCHITIS CHRONIC | 4 0.04 12.86 BRONCHOPNEUMONIA | 4 0.04 12.90 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 12.92 BRONCHOPULMONARY DYSPLASIA | 1 0.01 12.93 BURKITT'S LYMPHOMA | 18 0.18 13.11 BURSITIS | 1 0.01 13.12 BURSITIS INFECTIVE | 3 0.03 13.15 CALCIUM DEFICIENCY | 1 0.01 13.16 CANCER PAIN | 26 0.26 13.42 CAPSULAR CONTRACTURE ASSOCIATED WITH .. | 1 0.01 13.43 CARCINOID SYNDROME | 1 0.01 13.44 CARCINOID TUMOUR | 7 0.07 13.51 CARDIAC DISORDER | 20 0.20 13.71 CARDIAC FAILURE | 20 0.20 13.91 CARDIAC FAILURE CHRONIC | 1 0.01 13.92 CARDIAC FAILURE CONGESTIVE | 9 0.09 14.01 CARDIAC OPERATION | 3 0.03 14.04 CARDIAC STRESS TEST | 1 0.01 14.05 CARDIOMYOPATHY | 1 0.01 14.06 CARDIOVASCULAR DISORDER | 8 0.08 14.14 CARDIOVASCULAR EVENT PROPHYLAXIS | 4 0.04 14.18 CATAPLEXY | 1 0.01 14.19 CATARACT | 2 0.02 14.21 CATHETER PLACEMENT | 1 0.01 14.22 CELLULITIS | 4 0.04 14.26 CENTRAL PAIN SYNDROME | 1 0.01 14.27 CEREBRAL INFARCTION | 10 0.10 14.37 CEREBRAL TOXOPLASMOSIS | 2 0.02 14.39 CEREBROVASCULAR ACCIDENT | 2 0.02 14.41 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 6 0.06 14.47 CERVICITIS | 1 0.01 14.48 CHARLES BONNET SYNDROME | 2 0.02 14.50 CHEMOTHERAPY | 29 0.29 14.79 CHEST DISCOMFORT | 1 0.01 14.80 CHEST PAIN | 3 0.03 14.83 CHOLECYSTECTOMY | 1 0.01 14.84 CHOLECYSTITIS | 2 0.02 14.86 CHOLELITHIASIS | 1 0.01 14.87 CHOROIDAL NEOVASCULARISATION | 1 0.01 14.88 CHRONIC GRAFT VERSUS HOST DISEASE | 2 0.02 14.90 CHRONIC LYMPHOCYTIC LEUKAEMIA | 9 0.09 14.99 CHRONIC MYELOID LEUKAEMIA | 36 0.36 15.35 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 48 0.48 15.83 CHRONIC SINUSITIS | 1 0.01 15.84 COAGULOPATHY | 4 0.04 15.88 COLITIS | 6 0.06 15.94 COLITIS ULCERATIVE | 18 0.18 16.12 COLLAGEN DISORDER | 1 0.01 16.13 COLON CANCER | 22 0.22 16.35 COLON CANCER METASTATIC | 16 0.16 16.51 COLON NEOPLASM | 2 0.02 16.53 COLONOSCOPY | 3 0.03 16.56 COLORECTAL CANCER | 42 0.42 16.98 COLORECTAL CANCER METASTATIC | 18 0.18 17.16 COMPLEX PARTIAL SEIZURES | 1 0.01 17.17 COMPLEX REGIONAL PAIN SYNDROME | 2 0.02 17.19 COMPUTERISED TOMOGRAM | 7 0.07 17.26 COMPUTERISED TOMOGRAM ABDOMEN | 33 0.33 17.59 COMPUTERISED TOMOGRAM THORAX | 4 0.04 17.63 CONFUSIONAL STATE | 2 0.02 17.65 CONJUNCTIVITIS | 3 0.03 17.68 CONNECTIVE TISSUE DISORDER | 1 0.01 17.69 CONSTIPATION | 46 0.46 18.15 CONSTIPATION PROPHYLAXIS | 2 0.02 18.17 CONTINUOUS HAEMODIAFILTRATION | 1 0.01 18.18 CONTRACEPTION | 94 0.94 19.12 CONVULSION | 37 0.37 19.49 CONVULSION PROPHYLAXIS | 1 0.01 19.50 CORONARY ANGIOPLASTY | 1 0.01 19.51 CORONARY ARTERIAL STENT INSERTION | 5 0.05 19.56 CORONARY ARTERY BYPASS | 9 0.09 19.65 CORONARY ARTERY DISEASE | 12 0.12 19.77 COUGH | 18 0.18 19.95 CROHN'S DISEASE | 92 0.92 20.87 CUSHING'S SYNDROME | 1 0.01 20.88 CYST | 1 0.01 20.89 CYSTIC FIBROSIS | 1 0.01 20.90 CYSTINOSIS | 1 0.01 20.91 CYSTITIS | 3 0.03 20.94 CYSTITIS INTERSTITIAL | 1 0.01 20.95 CYSTITIS NONINFECTIVE | 1 0.01 20.96 CYTOMEGALOVIRUS INFECTION | 3 0.03 20.99 DECREASED APPETITE | 6 0.06 21.05 DEEP VEIN THROMBOSIS | 2 0.02 21.07 DEHYDRATION | 2 0.02 21.09 DELIRIUM | 2 0.02 21.11 DELIVERY | 4 0.04 21.15 DELUSION | 6 0.06 21.21 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 1 0.01 21.22 DEMENTIA | 9 0.09 21.31 DEMENTIA ALZHEIMER'S TYPE | 16 0.16 21.47 DENTAL DISORDER PROPHYLAXIS | 7 0.07 21.54 DENTAL FLUORIDE THERAPY | 1 0.01 21.55 DENTAL OPERATION | 1 0.01 21.56 DEPRESSED MOOD | 3 0.03 21.59 DEPRESSION | 203 2.03 23.62 DEPRESSIVE SYMPTOM | 5 0.05 23.67 DERMATITIS | 3 0.03 23.70 DERMATITIS ATOPIC | 9 0.09 23.79 DERMATOMYOSITIS | 5 0.05 23.84 DIABETES MELLITUS | 171 1.71 25.55 DIABETES PROPHYLAXIS | 1 0.01 25.56 DIABETIC NEUROPATHY | 6 0.06 25.62 DIABETIC RETINAL OEDEMA | 2 0.02 25.64 DIALYSIS | 3 0.03 25.67 DIARRHOEA | 15 0.15 25.82 DIFFUSE LARGE B-CELL LYMPHOMA | 65 0.65 26.47 DISBACTERIOSIS | 1 0.01 26.48 DISEASE PROGRESSION | 1 0.01 26.49 DISSEMINATED INTRAVASCULAR COAGULATION | 3 0.03 26.52 DIURETIC THERAPY | 5 0.05 26.57 DIVERTICULITIS | 2 0.02 26.59 DIZZINESS | 5 0.05 26.64 DRUG ABUSE | 1 0.01 26.65 DRUG DEPENDENCE | 3 0.03 26.68 DRUG EFFECT DECREASED | 1 0.01 26.69 DRUG EXPOSURE DURING PREGNANCY | 31 0.31 27.00 DRUG RESISTANCE | 1 0.01 27.01 DRUG THERAPY | 1 0.01 27.02 DRUG USE FOR UNKNOWN INDICATION | 1,878 18.78 45.80 DRY EYE | 1 0.01 45.81 DRY SKIN | 2 0.02 45.83 DUCHENNE MUSCULAR DYSTROPHY | 1 0.01 45.84 DYSLIPIDAEMIA | 6 0.06 45.90 DYSMENORRHOEA | 5 0.05 45.95 DYSPEPSIA | 18 0.18 46.13 DYSPNOEA | 10 0.10 46.23 DYSTONIA | 1 0.01 46.24 DYSURIA | 2 0.02 46.26 EAR INFECTION | 1 0.01 46.27 EATING DISORDER | 1 0.01 46.28 ECZEMA | 4 0.04 46.32 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 46.33 EMBOLISM VENOUS | 1 0.01 46.34 EMPHYSEMA | 10 0.10 46.44 ENDOCARDITIS | 9 0.09 46.53 ENDOMETRIAL CANCER | 11 0.11 46.64 ENDOMETRIAL CANCER METASTATIC | 1 0.01 46.65 ENDOMETRIOSIS | 4 0.04 46.69 ENTERITIS | 1 0.01 46.70 ENTEROCOCCAL SEPSIS | 2 0.02 46.72 ENTEROCOLITIS | 5 0.05 46.77 ENURESIS | 1 0.01 46.78 EPIDURAL ANAESTHESIA | 3 0.03 46.81 EPIGASTRIC DISCOMFORT | 1 0.01 46.82 EPILEPSY | 62 0.62 47.44 EPISTAXIS | 1 0.01 47.45 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 1 0.01 47.46 ERECTILE DYSFUNCTION | 17 0.17 47.63 ERYSIPELAS | 2 0.02 47.65 ERYTHEMA | 2 0.02 47.67 ESCHERICHIA INFECTION | 1 0.01 47.68 ESSENTIAL HYPERTENSION | 8 0.08 47.76 ESSENTIAL THROMBOCYTHAEMIA | 4 0.04 47.80 EVIDENCE BASED TREATMENT | 2 0.02 47.82 EXPOSURE TO COMMUNICABLE DISEASE | 1 0.01 47.83 EXTRACORPOREAL CIRCULATION | 2 0.02 47.85 EXTRAPYRAMIDAL DISORDER | 2 0.02 47.87 EYE INFECTION TOXOPLASMAL | 3 0.03 47.90 EYE PAIN | 1 0.01 47.91 EYE PRURITUS | 1 0.01 47.92 FABRY'S DISEASE | 2 0.02 47.94 FACIAL BONES FRACTURE | 1 0.01 47.95 FACIAL PAIN | 1 0.01 47.96 FACIAL SPASM | 2 0.02 47.98 FACTOR IX DEFICIENCY | 3 0.03 48.01 FACTOR VIII DEFICIENCY | 7 0.07 48.08 FATIGUE | 3 0.03 48.11 FEBRILE INFECTION | 2 0.02 48.13 FEBRILE NEUTROPENIA | 13 0.13 48.26 FERTILITY INCREASED | 1 0.01 48.27 FIBROMYALGIA | 23 0.23 48.50 FLUID IMBALANCE | 2 0.02 48.52 FLUID RETENTION | 4 0.04 48.56 FLUSHING | 1 0.01 48.57 FOLATE DEFICIENCY | 2 0.02 48.59 FRACTURE | 2 0.02 48.61 FUNGAL INFECTION | 4 0.04 48.65 GASTRIC CANCER | 14 0.14 48.79 GASTRIC CANCER STAGE IV | 2 0.02 48.81 GASTRIC DISORDER | 4 0.04 48.85 GASTRIC ULCER | 20 0.20 49.05 GASTRITIS | 17 0.17 49.22 GASTRITIS PROPHYLAXIS | 13 0.13 49.35 GASTRODUODENAL ULCER | 1 0.01 49.36 GASTROENTERITIS | 3 0.03 49.39 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 49.40 GASTROINTESTINAL HAEMORRHAGE | 2 0.02 49.42 GASTROINTESTINAL INFLAMMATION | 3 0.03 49.45 GASTROINTESTINAL NEOPLASM | 6 0.06 49.51 GASTROINTESTINAL STROMAL TUMOUR | 14 0.14 49.65 GASTROOESOPHAGEAL CANCER | 6 0.06 49.71 GASTROOESOPHAGEAL REFLUX DISEASE | 40 0.40 50.11 GASTROOESOPHAGEAL REFLUX PROPHYLAXIS | 1 0.01 50.12 GAUCHER'S DISEASE | 5 0.05 50.17 GENERAL ANAESTHESIA | 3 0.03 50.20 GENERALISED ANXIETY DISORDER | 2 0.02 50.22 GENITAL HERPES | 1 0.01 50.23 GLAUCOMA | 19 0.19 50.42 GLEICH'S SYNDROME | 2 0.02 50.44 GLIOBLASTOMA MULTIFORME | 4 0.04 50.48 GLIOMA | 3 0.03 50.51 GLIOMATOSIS CEREBRI | 9 0.09 50.60 GOUT | 11 0.11 50.71 GRAND MAL CONVULSION | 6 0.06 50.77 GROWTH HORMONE DEFICIENCY | 7 0.07 50.84 GROWTH RETARDATION | 1 0.01 50.85 GUILLAIN-BARRE SYNDROME | 1 0.01 50.86 HAEMANGIOMA | 1 0.01 50.87 HAEMARTHROSIS | 1 0.01 50.88 HAEMATURIA | 1 0.01 50.89 HAEMOCHROMATOSIS | 1 0.01 50.90 HAEMOLYSIS | 1 0.01 50.91 HAEMOPHILIA | 4 0.04 50.95 HAEMORRHAGE | 3 0.03 50.98 HAEMORRHOIDS | 1 0.01 50.99 HAEMOSIDEROSIS | 2 0.02 51.01 HAEMOSTASIS | 6 0.06 51.07 HAIRY CELL LEUKAEMIA | 1 0.01 51.08 HALLUCINATION | 7 0.07 51.15 HEAD AND NECK CANCER | 22 0.22 51.37 HEAD INJURY | 1 0.01 51.38 HEADACHE | 17 0.17 51.55 HEART DISEASE CONGENITAL | 1 0.01 51.56 HEART RATE | 1 0.01 51.57 HEART RATE INCREASED | 2 0.02 51.59 HEART RATE IRREGULAR | 3 0.03 51.62 HEART TRANSPLANT | 19 0.19 51.81 HEART VALVE REPLACEMENT | 4 0.04 51.85 HEPARIN-INDUCED THROMBOCYTOPENIA | 2 0.02 51.87 HEPATIC CANCER METASTATIC | 2 0.02 51.89 HEPATIC CIRRHOSIS | 2 0.02 51.91 HEPATIC ENCEPHALOPATHY | 1 0.01 51.92 HEPATIC FUNCTION ABNORMAL | 1 0.01 51.93 HEPATIC NEOPLASM MALIGNANT | 15 0.15 52.08 HEPATITIS | 1 0.01 52.09 HEPATITIS B | 15 0.15 52.24 HEPATITIS C | 36 0.36 52.60 HEPATITIS C VIRUS TEST | 1 0.01 52.61 HEPATOTOXICITY | 1 0.01 52.62 HEREDITARY ANGIOEDEMA | 1 0.01 52.63 HERNIA | 1 0.01 52.64 HERNIA REPAIR | 1 0.01 52.65 HERPES SIMPLEX | 3 0.03 52.68 HERPES VIRUS INFECTION | 3 0.03 52.71 HERPES ZOSTER | 13 0.13 52.84 HIATUS HERNIA | 4 0.04 52.88 HICCUPS | 2 0.02 52.90 HIGH DENSITY LIPOPROTEIN DECREASED | 2 0.02 52.92 HIP ARTHROPLASTY | 1 0.01 52.93 HIP FRACTURE | 1 0.01 52.94 HIV INFECTION | 188 1.88 54.82 HODGKIN'S DISEASE | 4 0.04 54.86 HORMONE LEVEL ABNORMAL | 3 0.03 54.89 HORMONE REPLACEMENT THERAPY | 219 2.19 57.08 HORMONE SUPPRESSION THERAPY | 4 0.04 57.12 HOT FLUSH | 3 0.03 57.15 HYPERCALCAEMIA | 2 0.02 57.17 HYPERCALCAEMIA OF MALIGNANCY | 1 0.01 57.18 HYPERCHLORHYDRIA | 2 0.02 57.20 HYPERCHOLESTEROLAEMIA | 39 0.39 57.59 HYPERGLYCAEMIA | 3 0.03 57.62 HYPERHIDROSIS | 2 0.02 57.64 HYPERKALAEMIA | 1 0.01 57.65 HYPERLIPIDAEMIA | 26 0.26 57.91 HYPERPARATHYROIDISM | 1 0.01 57.92 HYPERPARATHYROIDISM PRIMARY | 1 0.01 57.93 HYPERPARATHYROIDISM SECONDARY | 1 0.01 57.94 HYPERPHOSPHATAEMIA | 1 0.01 57.95 HYPERSENSITIVITY | 19 0.19 58.14 HYPERTENSION | 409 4.09 62.23 HYPERTENSIVE EMERGENCY | 1 0.01 62.24 HYPERTHERMIA | 2 0.02 62.26 HYPERTHYROIDISM | 2 0.02 62.28 HYPERTONIA | 1 0.01 62.29 HYPERTONIC BLADDER | 7 0.07 62.36 HYPERURICAEMIA | 7 0.07 62.43 HYPOAESTHESIA | 1 0.01 62.44 HYPOCALCAEMIA | 2 0.02 62.46 HYPOCOAGULABLE STATE | 1 0.01 62.47 HYPOGONADISM | 1 0.01 62.48 HYPOPITUITARISM | 3 0.03 62.51 HYPOPROTEINAEMIA | 1 0.01 62.52 HYPOTENSION | 4 0.04 62.56 HYPOTHYROIDISM | 32 0.32 62.88 HYPOTONIA | 1 0.01 62.89 HYPOVITAMINOSIS | 1 0.01 62.90 HYPOXIA | 1 0.01 62.91 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 23 0.23 63.14 IMMUNODEFICIENCY COMMON VARIABLE | 2 0.02 63.16 IMMUNOSUPPRESSANT DRUG THERAPY | 6 0.06 63.22 IMMUNOSUPPRESSION | 26 0.26 63.48 IMPAIRED GASTRIC EMPTYING | 1 0.01 63.49 INCONTINENCE | 2 0.02 63.51 INDUCTION AND MAINTENANCE OF ANAESTHE.. | 3 0.03 63.54 INDUCTION OF ANAESTHESIA | 14 0.14 63.68 INFECTION | 7 0.07 63.75 INFECTION PROPHYLAXIS | 19 0.19 63.94 INFERTILITY | 1 0.01 63.95 INFLAMMATION | 1 0.01 63.96 INFLAMMATORY BOWEL DISEASE | 16 0.16 64.12 INFLUENZA | 8 0.08 64.20 INJECTION | 1 0.01 64.21 INSOMNIA | 70 0.70 64.91 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 11 0.11 65.02 INTENTIONAL OVERDOSE | 1 0.01 65.03 INTERSTITIAL LUNG DISEASE | 3 0.03 65.06 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 65.07 INTERVERTEBRAL DISC PROTRUSION | 1 0.01 65.08 IRON DEFICIENCY | 2 0.02 65.10 IRON DEFICIENCY ANAEMIA | 3 0.03 65.13 IRON OVERLOAD | 6 0.06 65.19 IRRITABLE BOWEL SYNDROME | 4 0.04 65.23 ISCHAEMIA | 4 0.04 65.27 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 65.29 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 1 0.01 65.30 ISCHAEMIC STROKE | 3 0.03 65.33 JUVENILE ARTHRITIS | 6 0.06 65.39 KAPOSI'S SARCOMA | 2 0.02 65.41 KAWASAKI'S DISEASE | 3 0.03 65.44 KNEE ARTHROPLASTY | 1 0.01 65.45 LABOUR STIMULATION | 8 0.08 65.53 LARYNGEAL CANCER | 2 0.02 65.55 LATENT TUBERCULOSIS | 1 0.01 65.56 LEUKAEMIA RECURRENT | 1 0.01 65.57 LIBIDO DECREASED | 1 0.01 65.58 LIPIDS INCREASED | 2 0.02 65.60 LIVER DISORDER | 3 0.03 65.63 LIVER TRANSPLANT | 24 0.24 65.87 LOCAL ANAESTHESIA | 3 0.03 65.90 LOW DENSITY LIPOPROTEIN | 1 0.01 65.91 LOW DENSITY LIPOPROTEIN ABNORMAL | 1 0.01 65.92 LOWER RESPIRATORY TRACT INFECTION | 1 0.01 65.93 LUNG ADENOCARCINOMA | 1 0.01 65.94 LUNG ADENOCARCINOMA METASTATIC | 2 0.02 65.96 LUNG CANCER METASTATIC | 1 0.01 65.97 LUNG DISORDER | 2 0.02 65.99 LUNG INFECTION | 2 0.02 66.01 LUNG NEOPLASM | 2 0.02 66.03 LUNG NEOPLASM MALIGNANT | 6 0.06 66.09 LUNG TRANSPLANT | 3 0.03 66.12 LUPUS NEPHRITIS | 1 0.01 66.13 LYMPHATIC DISORDER | 2 0.02 66.15 LYMPHOMA | 24 0.24 66.39 LYMPHOMA AIDS RELATED | 5 0.05 66.44 MACULAR DEGENERATION | 23 0.23 66.67 MAINTENANCE OF ANAESTHESIA | 12 0.12 66.79 MAJOR DEPRESSION | 14 0.14 66.93 MALARIA | 1 0.01 66.94 MALARIA PROPHYLAXIS | 2 0.02 66.96 MALIGNANT GLIOMA | 1 0.01 66.97 MALIGNANT MAST CELL NEOPLASM | 3 0.03 67.00 MALIGNANT MELANOMA | 7 0.07 67.07 MALNUTRITION | 2 0.02 67.09 MANIA | 1 0.01 67.10 MANTLE CELL LYMPHOMA | 12 0.12 67.22 MEDICAL DIET | 1 0.01 67.23 MEDICATION DILUTION | 2 0.02 67.25 MEMORY IMPAIRMENT | 2 0.02 67.27 MENINGITIS BACTERIAL | 1 0.01 67.28 MENOPAUSAL SYMPTOMS | 9 0.09 67.37 MENOPAUSE | 15 0.15 67.52 MENORRHAGIA | 1 0.01 67.53 MENSTRUAL DISORDER | 1 0.01 67.54 MENSTRUATION IRREGULAR | 1 0.01 67.55 MENTAL DISORDER | 3 0.03 67.58 MESOTHELIOMA | 3 0.03 67.61 METABOLIC DISORDER | 2 0.02 67.63 METASTASES TO BONE | 20 0.20 67.83 METASTASES TO LUNG | 1 0.01 67.84 METASTASES TO RECTUM | 1 0.01 67.85 METASTASES TO SPINE | 1 0.01 67.86 METASTATIC GASTRIC CANCER | 12 0.12 67.98 METASTATIC MALIGNANT MELANOMA | 3 0.03 68.01 METASTATIC NEOPLASM | 3 0.03 68.04 METASTATIC PAIN | 1 0.01 68.05 METASTATIC RENAL CELL CARCINOMA | 7 0.07 68.12 METASTATIC UTERINE CANCER | 3 0.03 68.15 METRORRHAGIA | 1 0.01 68.16 MICTURITION DISORDER | 1 0.01 68.17 MICTURITION URGENCY | 2 0.02 68.19 MIGRAINE | 35 0.35 68.54 MIGRAINE PROPHYLAXIS | 3 0.03 68.57 MINERAL SUPPLEMENTATION | 5 0.05 68.62 MITRAL VALVE PROLAPSE | 1 0.01 68.63 MITRAL VALVE REPLACEMENT | 1 0.01 68.64 MOOD ALTERED | 1 0.01 68.65 MOOD SWINGS | 1 0.01 68.66 MUCOPOLYSACCHARIDOSIS I | 1 0.01 68.67 MUCOPOLYSACCHARIDOSIS II | 3 0.03 68.70 MUCORMYCOSIS | 2 0.02 68.72 MULTI-ORGAN FAILURE | 1 0.01 68.73 MULTIPLE ALLERGIES | 6 0.06 68.79 MULTIPLE MYELOMA | 99 0.99 69.78 MULTIPLE SCLEROSIS | 251 2.51 72.29 MULTIPLE SCLEROSIS RELAPSE | 3 0.03 72.32 MUSCLE BUILDING THERAPY | 2 0.02 72.34 MUSCLE MASS | 1 0.01 72.35 MUSCLE RELAXANT THERAPY | 3 0.03 72.38 MUSCLE SPASMS | 23 0.23 72.61 MUSCLE SPASTICITY | 5 0.05 72.66 MUSCLE STRAIN | 1 0.01 72.67 MUSCULOSKELETAL PAIN | 6 0.06 72.73 MUSCULOSKELETAL STIFFNESS | 4 0.04 72.77 MYALGIA | 1 0.01 72.78 MYCOBACTERIAL INFECTION | 1 0.01 72.79 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 3 0.03 72.82 MYELITIS TRANSVERSE | 1 0.01 72.83 MYELODYSPLASTIC SYNDROME | 25 0.25 73.08 MYELOFIBROSIS | 1 0.01 73.09 MYELOID LEUKAEMIA | 1 0.01 73.10 MYOCARDIAL INFARCTION | 9 0.09 73.19 MYOCARDIAL ISCHAEMIA | 8 0.08 73.27 MYRINGOTOMY | 17 0.17 73.44 NAIL DYSTROPHY | 1 0.01 73.45 NARCOLEPSY | 1 0.01 73.46 NASAL CONGESTION | 1 0.01 73.47 NASAL DISCOMFORT | 1 0.01 73.48 NASOPHARYNGITIS | 19 0.19 73.67 NAUSEA | 24 0.24 73.91 NECK PAIN | 6 0.06 73.97 NEOPLASM | 5 0.05 74.02 NEOPLASM MALIGNANT | 9 0.09 74.11 NEPHROBLASTOMA | 4 0.04 74.15 NEPHROPATHY | 1 0.01 74.16 NERVE BLOCK | 2 0.02 74.18 NERVOUSNESS | 2 0.02 74.20 NEURALGIA | 13 0.13 74.33 NEURITIS | 1 0.01 74.34 NEUROENDOCRINE CARCINOMA | 3 0.03 74.37 NEUROENDOCRINE TUMOUR | 13 0.13 74.50 NEUROGENIC BLADDER | 1 0.01 74.51 NEUROLOGICAL SYMPTOM | 1 0.01 74.52 NEUROPATHY PERIPHERAL | 13 0.13 74.65 NEUTROPENIA | 6 0.06 74.71 NON-HODGKIN'S LYMPHOMA | 18 0.18 74.89 NON-SMALL CELL LUNG CANCER | 51 0.51 75.40 NON-SMALL CELL LUNG CANCER METASTATIC | 7 0.07 75.47 NOONAN SYNDROME | 1 0.01 75.48 NORMAL TENSION GLAUCOMA | 1 0.01 75.49 NUCLEAR MAGNETIC RESONANCE IMAGING | 10 0.10 75.59 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 3 0.03 75.62 NULLIPAROUS | 1 0.01 75.63 NUTRITIONAL SUPPORT | 1 0.01 75.64 OBESITY | 6 0.06 75.70 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 75.72 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 75.73 OEDEMA | 2 0.02 75.75 OEDEMA DUE TO CARDIAC DISEASE | 1 0.01 75.76 OEDEMA PERIPHERAL | 6 0.06 75.82 OESOPHAGEAL ADENOCARCINOMA | 6 0.06 75.88 OESOPHAGEAL CARCINOMA | 7 0.07 75.95 OESOPHAGEAL DISORDER | 2 0.02 75.97 OESOPHAGEAL SQUAMOUS CELL CARCINOMA | 4 0.04 76.01 OESOPHAGEAL ULCER | 1 0.01 76.02 OESOPHAGITIS | 3 0.03 76.05 OESOPHAGOGASTRIC FUNDOPLASTY | 1 0.01 76.06 OFF LABEL USE | 5 0.05 76.11 ONYCHOMYCOSIS | 7 0.07 76.18 OPEN ANGLE GLAUCOMA | 2 0.02 76.20 OPPORTUNISTIC INFECTION | 1 0.01 76.21 OPTIC NEURITIS | 1 0.01 76.22 ORAL CONTRACEPTION | 2 0.02 76.24 ORAL FUNGAL INFECTION | 1 0.01 76.25 ORAL NEOPLASM | 1 0.01 76.26 ORCHITIS | 1 0.01 76.27 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 1 0.01 76.28 OROPHARYNGEAL PAIN | 2 0.02 76.30 ORTHOPEDIC PROCEDURE | 2 0.02 76.32 OSTEITIS DEFORMANS | 1 0.01 76.33 OSTEOARTHRITIS | 21 0.21 76.54 OSTEOLYSIS | 1 0.01 76.55 OSTEOMYELITIS | 1 0.01 76.56 OSTEOPENIA | 13 0.13 76.69 OSTEOPOROSIS | 144 1.44 78.13 OSTEOPOROSIS POSTMENOPAUSAL | 4 0.04 78.17 OSTEOPOROSIS PROPHYLAXIS | 14 0.14 78.31 OTITIS EXTERNA | 1 0.01 78.32 OTITIS MEDIA | 1 0.01 78.33 OTITIS MEDIA ACUTE | 1 0.01 78.34 OVARIAN CANCER | 3 0.03 78.37 OVARIAN CANCER RECURRENT | 4 0.04 78.41 OVARIAN CYST | 1 0.01 78.42 OVARIAN EPITHELIAL CANCER | 8 0.08 78.50 OVERDOSE | 7 0.07 78.57 OVERLAP SYNDROME | 1 0.01 78.58 OXYGEN SATURATION ABNORMAL | 1 0.01 78.59 PAIN | 130 1.30 79.89 PAIN IN EXTREMITY | 9 0.09 79.98 PAIN IN JAW | 1 0.01 79.99 PAIN MANAGEMENT | 3 0.03 80.02 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 80.03 PALPITATIONS | 2 0.02 80.05 PANCREAS TRANSPLANT | 1 0.01 80.06 PANCREATIC CARCINOMA | 6 0.06 80.12 PANCREATIC CARCINOMA METASTATIC | 1 0.01 80.13 PANCREATIC CARCINOMA STAGE III | 2 0.02 80.15 PANCREATIC DISORDER | 1 0.01 80.16 PANCREATIC NEUROENDOCRINE TUMOUR | 1 0.01 80.17 PANCREATITIS CHRONIC | 3 0.03 80.20 PANCYTOPENIA | 2 0.02 80.22 PANIC ATTACK | 6 0.06 80.28 PANIC DISORDER | 14 0.14 80.42 PANIC DISORDER WITH AGORAPHOBIA | 1 0.01 80.43 PARAESTHESIA | 1 0.01 80.44 PARANOIA | 2 0.02 80.46 PARATHYROID DISORDER | 1 0.01 80.47 PARENTERAL NUTRITION | 3 0.03 80.50 PARKINSON'S DISEASE | 21 0.21 80.71 PARKINSONISM | 5 0.05 80.76 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 8 0.08 80.84 PARTIAL SEIZURES | 8 0.08 80.92 PATERNAL DRUGS AFFECTING FOETUS | 2 0.02 80.94 PELVIC PAIN | 1 0.01 80.95 PEPTIC ULCER | 3 0.03 80.98 PERCUTANEOUS CORONARY INTERVENTION | 2 0.02 81.00 PERIARTHRITIS | 2 0.02 81.02 PERIODONTITIS | 1 0.01 81.03 PERIPHERAL SENSORY NEUROPATHY | 3 0.03 81.06 PERITONEAL DIALYSIS | 56 0.56 81.62 PETIT MAL EPILEPSY | 1 0.01 81.63 PHARYNGITIS | 1 0.01 81.64 PHLEBITIS | 3 0.03 81.67 PITUITARY TUMOUR BENIGN | 1 0.01 81.68 PLATELET COUNT DECREASED | 1 0.01 81.69 PLATELET COUNT INCREASED | 1 0.01 81.70 PLEURAL MESOTHELIOMA MALIGNANT | 2 0.02 81.72 PLEURAL NEOPLASM | 1 0.01 81.73 PNEUMOCYSTIS JIROVECI INFECTION | 12 0.12 81.85 PNEUMONIA | 19 0.19 82.04 PNEUMONIA ASPIRATION | 1 0.01 82.05 PNEUMONIA CRYPTOCOCCAL | 1 0.01 82.06 PNEUMONIA ESCHERICHIA | 1 0.01 82.07 PNEUMONIA MYCOPLASMAL | 1 0.01 82.08 POLLAKIURIA | 7 0.07 82.15 POLYARTHRITIS | 2 0.02 82.17 POLYCYTHAEMIA VERA | 1 0.01 82.18 POLYMYALGIA RHEUMATICA | 3 0.03 82.21 POOR QUALITY SLEEP | 1 0.01 82.22 POST HERPETIC NEURALGIA | 1 0.01 82.23 POST PROCEDURAL HYPOTHYROIDISM | 1 0.01 82.24 POST PROCEDURAL SEPSIS | 1 0.01 82.25 POST-THORACOTOMY PAIN SYNDROME | 4 0.04 82.29 POST-TRAUMATIC EPILEPSY | 1 0.01 82.30 POST-TRAUMATIC STRESS DISORDER | 6 0.06 82.36 POSTNASAL DRIP | 2 0.02 82.38 POSTOPERATIVE WOUND INFECTION | 1 0.01 82.39 POSTPARTUM DEPRESSION | 1 0.01 82.40 PRECANCEROUS SKIN LESION | 1 0.01 82.41 PRECOCIOUS PUBERTY | 2 0.02 82.43 PREGNANCY | 2 0.02 82.45 PREMATURE EJACULATION | 1 0.01 82.46 PREMATURE LABOUR | 1 0.01 82.47 PREMATURE MENOPAUSE | 1 0.01 82.48 PREMEDICATION | 45 0.45 82.93 PROCEDURAL PAIN | 5 0.05 82.98 PRODUCTIVE COUGH | 4 0.04 83.02 PROGRESSIVE RELAPSING MULTIPLE SCLERO.. | 1 0.01 83.03 PROLACTINOMA | 1 0.01 83.04 PROPHYLAXIS | 139 1.39 84.43 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 9 0.09 84.52 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 10 0.10 84.62 PROPHYLAXIS AGAINST HIV INFECTION | 4 0.04 84.66 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 32 0.32 84.98 PROPHYLAXIS OF ABORTION | 1 0.01 84.99 PROPHYLAXIS OF NAUSEA AND VOMITING | 9 0.09 85.08 PROPHYLAXIS OF NEURAL TUBE DEFECT | 4 0.04 85.12 PROSTATE CANCER | 29 0.29 85.41 PROSTATE CANCER METASTATIC | 3 0.03 85.44 PROSTATE CANCER STAGE II | 1 0.01 85.45 PROSTATE CANCER STAGE III | 4 0.04 85.49 PROSTATE CANCER STAGE IV | 14 0.14 85.63 PROSTATE INFECTION | 1 0.01 85.64 PROSTATIC DISORDER | 3 0.03 85.67 PROSTATISM | 1 0.01 85.68 PROSTATITIS | 1 0.01 85.69 PROSTATOMEGALY | 2 0.02 85.71 PRURITUS | 8 0.08 85.79 PSORIASIS | 33 0.33 86.12 PSORIATIC ARTHROPATHY | 12 0.12 86.24 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 86.26 PSYCHOTIC DISORDER | 25 0.25 86.51 PTERYGIUM | 1 0.01 86.52 PULMONARY ARTERIAL HYPERTENSION | 27 0.27 86.79 PULMONARY CONGESTION | 1 0.01 86.80 PULMONARY EMBOLISM | 5 0.05 86.85 PULMONARY FIBROSIS | 1 0.01 86.86 PULMONARY HYPERTENSION | 6 0.06 86.92 PULMONARY TUBERCULOSIS | 1 0.01 86.93 PUSTULAR PSORIASIS | 1 0.01 86.94 PYELONEPHRITIS | 2 0.02 86.96 PYELONEPHRITIS ACUTE | 1 0.01 86.97 PYODERMA GANGRENOSUM | 1 0.01 86.98 PYREXIA | 21 0.21 87.19 RADICULOPATHY | 1 0.01 87.20 RADIOACTIVE IODINE THERAPY | 12 0.12 87.32 RASH | 8 0.08 87.40 RAYNAUD'S PHENOMENON | 1 0.01 87.41 RECONCILIATION WITH PARTNER | 1 0.01 87.42 RECTAL CANCER | 11 0.11 87.53 RECTAL CANCER METASTATIC | 1 0.01 87.54 RECTOSIGMOID CANCER | 3 0.03 87.57 REFLUX GASTRITIS | 3 0.03 87.60 REFLUX OESOPHAGITIS | 7 0.07 87.67 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 17 0.17 87.84 RELAXATION THERAPY | 1 0.01 87.85 RENAL AMYLOIDOSIS | 1 0.01 87.86 RENAL CANCER | 6 0.06 87.92 RENAL CANCER METASTATIC | 4 0.04 87.96 RENAL CELL CARCINOMA | 34 0.34 88.30 RENAL CELL CARCINOMA STAGE I | 1 0.01 88.31 RENAL CELL CARCINOMA STAGE II | 1 0.01 88.32 RENAL CELL CARCINOMA STAGE IV | 9 0.09 88.41 RENAL DISORDER | 8 0.08 88.49 RENAL FAILURE | 5 0.05 88.54 RENAL FAILURE CHRONIC | 19 0.19 88.73 RENAL IMPAIRMENT | 2 0.02 88.75 RENAL TRANSPLANT | 95 0.95 89.70 RESORPTION BONE INCREASED | 1 0.01 89.71 RESPIRATORY DISORDER | 3 0.03 89.74 RESPIRATORY TRACT INFECTION | 3 0.03 89.77 RESTLESS LEGS SYNDROME | 4 0.04 89.81 RESTLESSNESS | 1 0.01 89.82 RESUSCITATION | 2 0.02 89.84 RETINAL OPERATION | 1 0.01 89.85 RETINAL VEIN OCCLUSION | 1 0.01 89.86 RHEUMATOID ARTHRITIS | 291 2.91 92.77 RHINITIS | 5 0.05 92.82 RHINITIS ALLERGIC | 3 0.03 92.85 ROUTINE HEALTH MAINTENANCE | 3 0.03 92.88 SARCOIDOSIS | 2 0.02 92.90 SARCOMA | 2 0.02 92.92 SCAN | 1 0.01 92.93 SCAN BRAIN | 2 0.02 92.95 SCAN THYROID GLAND | 1 0.01 92.96 SCHIZOAFFECTIVE DISORDER | 7 0.07 93.03 SCHIZOAFFECTIVE DISORDER DEPRESSIVE T.. | 1 0.01 93.04 SCHIZOPHRENIA | 83 0.83 93.87 SCHIZOPHRENIA, PARANOID TYPE | 16 0.16 94.03 SCHIZOPHRENIA, UNDIFFERENTIATED TYPE | 1 0.01 94.04 SCIATICA | 3 0.03 94.07 SEASONAL ALLERGY | 4 0.04 94.11 SECONDARY ADRENOCORTICAL INSUFFICIENCY | 1 0.01 94.12 SECONDARY HYPOTHYROIDISM | 2 0.02 94.14 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 94.15 SEDATION | 5 0.05 94.20 SEDATIVE THERAPY | 2 0.02 94.22 SENILE OSTEOPOROSIS | 1 0.01 94.23 SEPSIS | 15 0.15 94.38 SEPTIC SHOCK | 2 0.02 94.40 SERONEGATIVE ARTHRITIS | 1 0.01 94.41 SHOCK | 1 0.01 94.42 SICKLE CELL ANAEMIA | 4 0.04 94.46 SIDEROBLASTIC ANAEMIA | 1 0.01 94.47 SINUS CONGESTION | 1 0.01 94.48 SINUS DISORDER | 3 0.03 94.51 SINUS HEADACHE | 1 0.01 94.52 SINUSITIS | 16 0.16 94.68 SINUSITIS ASPERGILLUS | 2 0.02 94.70 SJOGREN'S SYNDROME | 2 0.02 94.72 SKIN INFECTION | 2 0.02 94.74 SKIN IRRITATION | 1 0.01 94.75 SKIN LESION | 5 0.05 94.80 SKIN PAPILLOMA | 1 0.01 94.81 SKIN REACTION | 1 0.01 94.82 SKIN ULCER | 2 0.02 94.84 SKIN WRINKLING | 3 0.03 94.87 SLEEP DISORDER | 34 0.34 95.21 SLEEP DISORDER THERAPY | 1 0.01 95.22 SMALL INTESTINE CARCINOMA | 1 0.01 95.23 SMOKING CESSATION THERAPY | 32 0.32 95.55 SOCIAL PHOBIA | 1 0.01 95.56 SOMNOLENCE | 1 0.01 95.57 SPINAL ANAESTHESIA | 2 0.02 95.59 SPINAL MUSCULAR ATROPHY | 1 0.01 95.60 SPONDYLITIS | 1 0.01 95.61 SPONDYLOARTHROPATHY | 1 0.01 95.62 SQUAMOUS CELL CARCINOMA | 1 0.01 95.63 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 95.64 STAPHYLOCOCCAL INFECTION | 6 0.06 95.70 STAPHYLOCOCCAL SEPSIS | 1 0.01 95.71 STEM CELL TRANSPLANT | 21 0.21 95.92 STENT PLACEMENT | 5 0.05 95.97 STRESS ULCER | 1 0.01 95.98 SUICIDAL IDEATION | 2 0.02 96.00 SUICIDE ATTEMPT | 2 0.02 96.02 SUPPLEMENTATION THERAPY | 6 0.06 96.08 SUPRAVENTRICULAR TACHYCARDIA | 3 0.03 96.11 SURGERY | 6 0.06 96.17 SWELLING | 6 0.06 96.23 SYSTEMIC CANDIDA | 1 0.01 96.24 SYSTEMIC LUPUS ERYTHEMATOSUS | 9 0.09 96.33 SYSTEMIC SCLEROSIS | 2 0.02 96.35 T-CELL LYMPHOMA | 2 0.02 96.37 TACHYCARDIA | 2 0.02 96.39 TEMPORAL LOBE EPILEPSY | 1 0.01 96.40 TENDON PAIN | 1 0.01 96.41 TERATOMA | 3 0.03 96.44 TESTICULAR NEOPLASM | 9 0.09 96.53 TESTIS CANCER | 1 0.01 96.54 THALASSAEMIA | 1 0.01 96.55 THERAPEUTIC EMBOLISATION | 12 0.12 96.67 THREATENED LABOUR | 3 0.03 96.70 THROAT IRRITATION | 1 0.01 96.71 THROMBECTOMY | 1 0.01 96.72 THROMBOCYTOPENIA | 8 0.08 96.80 THROMBOSIS | 3 0.03 96.83 THROMBOSIS PROPHYLAXIS | 22 0.22 97.05 THYMUS DISORDER | 1 0.01 97.06 THYROID CANCER | 2 0.02 97.08 THYROID DISORDER | 9 0.09 97.17 THYROID HAEMORRHAGE | 1 0.01 97.18 THYROIDECTOMY | 1 0.01 97.19 TINEA INFECTION | 2 0.02 97.21 TOBACCO USER | 1 0.01 97.22 TONGUE OEDEMA | 2 0.02 97.24 TONGUE TIE OPERATION | 2 0.02 97.26 TONSILLECTOMY | 12 0.12 97.38 TONSILLITIS | 1 0.01 97.39 TOOTH ABSCESS | 3 0.03 97.42 TOOTHACHE | 4 0.04 97.46 TORTICOLLIS | 1 0.01 97.47 TOURETTE'S DISORDER | 1 0.01 97.48 TRACHOMA | 1 0.01 97.49 TRANSIENT ISCHAEMIC ATTACK | 3 0.03 97.52 TRANSITIONAL CELL CARCINOMA | 1 0.01 97.53 TRANSPLANT REJECTION | 3 0.03 97.56 TRAUMATIC ARTHRITIS | 4 0.04 97.60 TREMOR | 1 0.01 97.61 TRIGEMINAL NEURALGIA | 2 0.02 97.63 TUBERCULIN TEST | 7 0.07 97.70 TUBERCULOSIS | 2 0.02 97.72 TUMOUR ASSOCIATED FEVER | 2 0.02 97.74 TUMOUR LYSIS SYNDROME | 1 0.01 97.75 TUMOUR PAIN | 1 0.01 97.76 TURNER'S SYNDROME | 1 0.01 97.77 TYPE 1 DIABETES MELLITUS | 16 0.16 97.93 TYPE 2 DIABETES MELLITUS | 97 0.97 98.90 TYPE IIA HYPERLIPIDAEMIA | 2 0.02 98.92 TYROSINAEMIA | 1 0.01 98.93 ULCER | 1 0.01 98.94 ULCER HAEMORRHAGE | 1 0.01 98.95 UNEVALUABLE EVENT | 4 0.04 98.99 UPPER RESPIRATORY TRACT INFECTION | 2 0.02 99.01 UPPER RESPIRATORY TRACT INFLAMMATION | 4 0.04 99.05 URETHRITIS | 1 0.01 99.06 URINARY INCONTINENCE | 3 0.03 99.09 URINARY RETENTION | 1 0.01 99.10 URINARY TRACT DISORDER | 2 0.02 99.12 URINARY TRACT INFECTION | 21 0.21 99.33 URINE OUTPUT DECREASED | 1 0.01 99.34 URTICARIA | 2 0.02 99.36 URTICARIA CHRONIC | 2 0.02 99.38 UTERINE CANCER | 3 0.03 99.41 UVEITIS | 2 0.02 99.43 VAGINAL HAEMORRHAGE | 1 0.01 99.44 VAGINAL INFECTION | 1 0.01 99.45 VASCULAR DEMENTIA | 1 0.01 99.46 VASCULAR GRAFT | 2 0.02 99.48 VASODILATATION | 2 0.02 99.50 VASODILATION PROCEDURE | 1 0.01 99.51 VENOUS INSUFFICIENCY | 1 0.01 99.52 VENTRICULAR ARRHYTHMIA | 1 0.01 99.53 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.54 VENTRICULAR TACHYCARDIA | 1 0.01 99.55 VERTIGO | 3 0.03 99.58 VISUAL IMPAIRMENT | 1 0.01 99.59 VITAMIN B12 DEFICIENCY | 2 0.02 99.61 VITAMIN C | 1 0.01 99.62 VITAMIN D DEFICIENCY | 3 0.03 99.65 VITAMIN SUPPLEMENTATION | 17 0.17 99.82 VOGT-KOYANAGI-HARADA SYNDROME | 1 0.01 99.83 VOMITING | 8 0.08 99.91 WALDENSTROM'S MACROGLOBULINAEMIA | 2 0.02 99.93 WEIGHT CONTROL | 2 0.02 99.95 WEIGHT DECREASED | 2 0.02 99.97 WEIGHT LOSS DIET | 2 0.02 99.99 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015